Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 19251-19300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06752304
A Longitudinal Study of Severe and Enduring Eating Disorders
N/ARecruiting
800 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2048
5 conditions4 sponsors1 location
NCT06845709
Effects of Otago and Gaze Stabilization Exercises on Balance, Gait and QOL in Elderly Stroke Patients
NARecruiting
46 participants
Started: Sep 1, 2024 · Completed: Apr 15, 2025
3 conditions1 sponsor1 location
NCT06751940
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NARecruiting
10 participants
Started: Sep 1, 2024 · Completed: Feb 28, 2027
1 condition1 sponsor2 locations
NCT06534710
Effect of Electronic Moxibustion Apparatus on Pain Degree and Wound Healing of Patients After Craniocerebral Surgery
NARecruiting
228 participants
Started: Sep 1, 2024 · Completed: Aug 1, 2025
1 condition1 sponsor1 location
NCT06826573
Analysis of Risk Factors for High Intraocular Pressure and Retinal Detachment Recurrence After Vitrectomy with Silicone Oil Tamponade in Retinal Detachment Patients
N/ARecruiting
65 participants
Started: Sep 1, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06507150
AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance
NARecruiting
140 participants
Started: Sep 1, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06540989
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
EARLY_PHASE1Recruiting
42 participants
Started: Sep 1, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06467799
Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC
PHASE2Recruiting
39 participants
Started: Sep 1, 2024 · Completed: Sep 1, 2027
2 conditions1 sponsor1 location
NCT06501001
Time Restricted Eating (TRE) and High-Intensity Interval Training (HIIT) to Improve Health in Patients With Metabolic Syndrome (METS)
NARecruiting
200 participants
Started: Sep 1, 2024 · Completed: Sep 30, 2026
6 conditions1 sponsor1 location
NCT06883175
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
NARecruiting
575 participants
Started: Sep 1, 2024 · Completed: Jun 30, 2029
3 conditions2 sponsors1 location
NCT06821373
Chatbot Intervention to Reduce Common Digital Addictions, Sedentary Behaviors and Mental Distress Among Adolescents
NARecruiting
330 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT07118436
Liquid Biopsy Under PSMA Radioligand Therapy
N/ARecruiting
100 participants
Started: Sep 1, 2024 · Completed: Aug 31, 2028
2 conditions4 sponsors3 locations
NCT05922124
Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii
PHASE4Recruiting
734 participants
Started: Sep 1, 2024 · Completed: Sep 30, 2026
3 conditions6 sponsors3 locations
NCT06550453
Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer
PHASE4Recruiting
20 participants
Started: Sep 1, 2024 · Completed: Jan 15, 2026
1 condition1 sponsor1 location
NCT06970977
CRS Questionnaire Validation Project
N/ARecruiting
1,000 participants
Started: Sep 1, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor32 locations
NCT05748808
Use of Biofeedback and Virtual Reality as Facilitators of Emotional Recognition in the Treatment of Aggressive Outbursts
NARecruiting
60 participants
Started: Sep 1, 2024 · Completed: Sep 1, 2025
1 condition2 sponsors1 location
NCT05829109
Fecal Microbiota Transplant for Patients With Chronic Pouchitis
EARLY_PHASE1Recruiting
16 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06268964
Exploring Treatments for Children's Abdominal Pain: Comparing Trimebutine and Probiotics
PHASE1/PHASE2Recruiting
82 participants
Started: Sep 1, 2024 · Completed: Jun 30, 2025
3 conditions1 sponsor1 location
NCT06551168
Heat Acclimation in Females
NARecruiting
14 participants
Started: Sep 1, 2024 · Completed: Apr 24, 2026
3 conditions1 sponsor1 location
NCT06207084
The Fit with Us Study
NARecruiting
257 participants
Started: Sep 1, 2024 · Completed: Feb 1, 2029
12 conditions1 sponsor1 location
NCT06523335
Improving Independent Multi-joint Arm Control After Stroke
NARecruiting
74 participants
Started: Sep 1, 2024 · Completed: Sep 1, 2029
1 condition3 sponsors1 location
NCT06588777
Ultrasound Guided Modified Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) Versus Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy
NARecruiting
52 participants
Started: Sep 1, 2024 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT06921668
Perioperative Dynamics of Energy Expenditure in Oesophagectomy Patients
N/ARecruiting
120 participants
Started: Sep 1, 2024 · Completed: Jan 2, 2028
1 condition1 sponsor4 locations
NCT06296186
Massed Prolonged Exposure for PTSD in Substance Use Treatment
NARecruiting
200 participants
Started: Sep 1, 2024 · Completed: Aug 31, 2027
2 conditions3 sponsors4 locations
NCT06369870
Interpectoral-pectoserratus Plane Block for Minimally Invasive Aortic Valve Replacement Via Right Anterior Minithoracotomy
PHASE4Recruiting
144 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06595992
Prospective Observational Cohort Study of Moderate Aortic Valve Disease
N/ARecruiting
1,000 participants
Started: Sep 1, 2024 · Completed: Jan 31, 2034
3 conditions1 sponsor1 location
NCT06581016
Performance Characteristics and Technical Outcomes of Single-use Vs. Reusable Gastroscopes Evaluated in the or
NARecruiting
700 participants
Started: Sep 1, 2024 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT06271031
Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
N/ARecruiting
100 participants
Started: Sep 1, 2024 · Completed: Mar 31, 2026
3 conditions1 sponsor1 location
NCT06338774
Cognitive Control to Boost Physical Activity Adherence
NARecruiting
264 participants
Started: Sep 1, 2024 · Completed: Nov 30, 2027
1 condition3 sponsors2 locations
NCT05213429
Middle East Coronary Artery Ectasia Registry
N/ARecruiting
11,000 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06593613
Pilot Trial of the RUBI Program for Autistic Adults
NARecruiting
80 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2024
3 conditions4 sponsors3 locations
NCT05188859
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
PHASE2Recruiting
29 participants
Started: Sep 1, 2024 · Completed: Sep 30, 2027
3 conditions1 sponsor2 locations
NCT06592235
Awareness of Individuals with Chronic Lung Disease About Climate Change, Heat Waves, Air Pollution and Physical Activity
N/ARecruiting
80 participants
Started: Sep 1, 2024 · Completed: Aug 1, 2025
3 conditions1 sponsor1 location
NCT06590805
Electroacupoint for Diminutive Milk Production
NARecruiting
36 participants
Started: Sep 1, 2024 · Completed: Jun 1, 2025
3 conditions1 sponsor1 location
NCT06584006
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
PHASE2Recruiting
50 participants
Started: Sep 1, 2024 · Completed: Feb 29, 2028
2 conditions1 sponsor1 location
NCT06108414
Low-dose Versus Standard-dose Rivaroxaban in Elderly Patients With Atrial Fibrillation
PHASE4Recruiting
4,374 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2027
4 conditions1 sponsor1 location
NCT06577155
Spinal Nalbuphine for Analgesia in Total Hip Arthroplasty
PHASE2Recruiting
60 participants
Started: Sep 1, 2024 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT06603376
Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer
PHASE2Recruiting
75 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06782217
Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
N/ARecruiting
120 participants
Started: Sep 1, 2024 · Completed: Feb 1, 2027
3 conditions1 sponsor9 locations
NCT06603792
Neurofeedback for the Management of Neuropathic Pain in People with Diabetes
EARLY_PHASE1Recruiting
54 participants
Started: Sep 1, 2024 · Completed: Jun 30, 2026
1 condition6 sponsors1 location
NCT06015022
EGCG for Hepatocellular Carcinoma Chemoprevention
PHASE2Recruiting
60 participants
Started: Sep 1, 2024 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06591338
Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA
PHASE3Recruiting
900 participants
Started: Sep 1, 2024 · Completed: Oct 10, 2025
1 condition1 sponsor1 location
NCT06239974
Vericiguat in Patients With Coronary Microvascular Dysfunction Causing Stable Chest Pain (V-COM)
NARecruiting
94 participants
Started: Sep 1, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06486168
Incidence of Diaphragmatic Dysfunction After Non-Intubated Video-Assisted Thoracoscopic Surgery
NARecruiting
100 participants
Started: Sep 1, 2024 · Completed: Sep 2, 2025
1 condition1 sponsor1 location
NCT06718972
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
N/ARecruiting
1,000 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2028
2 conditions1 sponsor2 locations
NCT07145008
Suprachoroidal Triamcinolone in Macular Edema for Patients With Non-Infectious Uveitis Resistant to Subtenon Triamcinolon
EARLY_PHASE1Recruiting
20 participants
Started: Sep 1, 2024 · Completed: Dec 1, 2026
2 conditions1 sponsor1 location
NCT07145086
Translaryngeal Vibration for Hyperfunctional Voice Disorders
PHASE3Recruiting
30 participants
Started: Sep 1, 2024 · Completed: Aug 31, 2027
2 conditions2 sponsors1 location
NCT06539793
Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome
NARecruiting
40 participants
Started: Sep 1, 2024 · Completed: Jul 3, 2025
1 condition1 sponsor1 location
NCT06835127
Ultra-low Dose Contrast for Endovascular Procedures
N/ARecruiting
15 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06986096
Lifestyle for the BRAin Health - Nutrition and Exercise Training Intervention
NARecruiting
40 participants
Started: Sep 1, 2024 · Completed: Dec 31, 2026
5 conditions1 sponsor1 location